Citation Impact
Citing Papers
Phase II Trial of Sorafenib in Advanced Thyroid Cancer
2008
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Myocarditis susceptibility in female mice depends upon ovarian cycle phase at infection
2004
Recent advances in functional supramolecular nanostructures assembled from bioactive building blocks
2009
Molecular imaging in drug development
2008 Standout
Pancreatic cancer
2004 Standout
Preparation of a Promising Angiogenesis PET Imaging Agent: 68Ga-Labeled c(RGDyK)–Isothiocyanatobenzyl-1,4,7-Triazacyclononane-1,4,7-Triacetic Acid and Feasibility Studies in Mice
2008
68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging
2009
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Novel “Add-On” Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents
2016
Ovarian cancer
2014 Standout
Taking advantage of luminescent lanthanide ions
2005 Standout
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Prodrug Strategies in Anticancer Chemotherapy
2007
Integrin αβ3-Targeted Imaging of Lung Cancer
2005
Head and neck cancer
2008 Standout
αvβ3 Integrin‐targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide
2006
MicroPET imaging of breast cancer ?-integrin expression with Cu-labeled dimeric RGD peptides
2004
αvβ3-integrin imaging: a new approach to characterise angiogenesis?
2006
Expression of Drug Resistance‐related Genes in Head and Neck Squamous Cell Carcinoma and Normal Mucosa
2000
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Clinical resistance to topoisomerase-targeted drugs
1998
Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes
2007
Human papillomavirus and cervical cancer
2007 Standout
Strain‐Promoted Copper‐Free “Click” Chemistry for 18F Radiolabeling of Bombesin
2011 StandoutNobel
MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide
2004
The role of coordination chemistry in the development of target-specific radiopharmaceuticals
2004
αvβ3 Integrin‐targeting radionuclide therapy and imaging with monomeric RGD peptide
2008
Clinical development of platinum complexes in cancer therapy: an historical perspective and an update
1998
3,3′-Diindolylmethane Is a Novel Topoisomerase IIα Catalytic Inhibitor That Induces S-Phase Retardation and Mitotic Delay in Human Hepatoma HepG2 Cells
2005
Integrin αvβ3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy
2011
Efficient microwave-assisted synthesis of multivalent dendrimeric peptides using cycloaddition reaction (click) chemistry
2005
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle
2004
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Current methods of testing for human papillomavirus
2001
Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation
2004
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor v 3 Integrin Expression
2007
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Recent insights into platinum drug resistance in cancer
1998
Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence
2005
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Myocarditis
2009 Standout
Lobaplatin
2003
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
2005
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Specific Targeting of Tumor Angiogenesis by RGD-Conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a Clinical 1.5-T Magnetic Resonance Scanner
2007
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
2006
Metalle in der Medizin
1999
Synthesis, Characterization, and X-ray Crystal Structure of In(DOTA-AA) (AA = p-Aminoanilide): A Model for 111In-Labeled DOTA-Biomolecule Conjugates
2003
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
2005
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Positron Emission Tomography As an Imaging Biomarker
2006
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
2012
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.
2001
Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
2005
Current status of trans-platinum compounds in cancer therapy
2001
Additions to Metal-Activated Organonitriles
2002 Standout
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
1999
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Synthesis and Cell Adhesive Properties of Linear and Cyclic RGD Functionalized Polynorbornene Thin Films
2012 Nobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Topoisomerase I Inhibitors: An Overview of the Camptothecin Analogs
1994
In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin αvβ3
2006
How molecular imaging is speeding up antiangiogenic drug development
2006
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
2012
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
2006
In vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain Tumor Xenografts
2004
Synthesis, Characterization, and Structures of Indium In(DTPA-BA2) and Yttrium Y(DTPA-BA2)(CH3OH) Complexes (BA = Benzylamine): Models for 111In- and 90Y-Labeled DTPA-Biomolecule Conjugates
2004
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Improving Tumor Uptake and Pharmacokinetics of 64Cu-Labeled Cyclic RGD Peptide Dimers with Gly3 and PEG4 Linkers
2009
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Targeted Disruption of the Mouse Topoisomerase I Gene by Camptothecin Selection
1996 StandoutNobel
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Therapeutic Synergy Between Irinotecan and 5-Fluorouracil against Human Tumor Xenografts
2004
Interactions of antitumoral platinum-group metallodrugs with albumin
2002
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Minute dosages of α ν β 3 ‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits
2008
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of H. Boonstra being referenced
Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle
2002
Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer
1995
Short Fragment Polymerase Chain Reaction Reverse Hybridization Line Probe Assay to Detect and Genotype a Broad Spectrum of Human Papillomavirus Types
1999
The role of genotype‐specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia
2002
Carboplatin with cyclophosphamide in patients with advanced ovarian cancer: an efficacy and quality-adjusted survival analysis
1992
Early detection of breast and ovarian cancer in families with BRCA mutations
2005
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.
1991
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
2002
Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers
2007
Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
1994
Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix
1996